National Healthcare Properties Inc. has drawn investor orders at $12 per share for its initial public offering, a level that sits beneath the $13 to $16 range the company marketed to investors.
Demand is coming from long-only funds and investors dedicated to the healthcare sector, and the offering has been described as multiple times oversubscribed. The deal is slated to be priced following the close of trading in New York on Tuesday.
Management intends for the company's common stock to begin trading on the Nasdaq Global Select Market under the ticker NHP. A group of underwriters is coordinating the sale, with Wells Fargo & Co., Morgan Stanley, Bank of Montreal, Goldman Sachs Group Inc. and Royal Bank of Canada listed among the banks working on the transaction.
The order indications at $12 and the report of multiple oversubscriptions present a mixed signal: pricing is below the marketed range even as the deal attracted several bids from institutional buyers focused on long-duration holdings and health-sector strategies. The final price will be set after the market close on Tuesday, and listing under the NHP symbol is expected to follow.
Offer mechanics and timeline
- Orders were recorded at $12 per share, below the marketed range of $13 to $16.
- The offering has been described as multiple times oversubscribed.
- Pricing is expected to occur after the New York market close on Tuesday, with trading to commence on the Nasdaq Global Select Market under the symbol NHP.
- Wells Fargo & Co., Morgan Stanley, Bank of Montreal, Goldman Sachs Group Inc. and Royal Bank of Canada are among the banks handling the offering.
Context and immediate implications
Orders at $12 indicate that institutional demand exists for shares of the senior housing and healthcare-focused real estate investment trust, drawing interest from both long-only investors and those concentrating on healthcare assets. At the same time, the fact that bids are below the initially marketed $13 to $16 range means the final offer price will reflect investor willingness to acquire shares at the lower level when the deal prices after the market close.
Because the offering is scheduled to price later on Tuesday and the first public trading under NHP has not yet commenced, outcomes for secondary-market performance and investor returns will only be known once the IPO completes and trading begins.